tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BLTE Stock Latest News

Belite Bio granted Sakigake Designation by Japan MHLW
The FlyBelite Bio granted Sakigake Designation by Japan MHLW
25d ago
BLTE
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan
PremiumPress Releases
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan
25d ago
BLTE
Belite Bio Advances Retinal Disease Treatment
PremiumCompany Announcements
Belite Bio Advances Retinal Disease Treatment
2M ago
6K
BLTE
Belite Bio reports Q1 EPS (33c), consensus (28c)
PremiumThe Fly
Belite Bio reports Q1 EPS (33c), consensus (28c)
2M ago
BLTE
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
2M ago
BLTE
Belite Bio participates in a webinar with Cantor Fitzgerald
PremiumThe FlyBelite Bio participates in a webinar with Cantor Fitzgerald
2M ago
BLTE
Belite Bio participates in a webinar with Cantor Fitzgerald
PremiumThe Fly
Belite Bio participates in a webinar with Cantor Fitzgerald
2M ago
BLTE
Belite Bio participates in a webinar with Cantor Fitzgerald
PremiumThe Fly
Belite Bio participates in a webinar with Cantor Fitzgerald
2M ago
BLTE
Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
PremiumPress Releases
Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
2M ago
BLTE
Belite Bio presents additional analysis from Phase 2 study of tinlarebant
PremiumThe Fly
Belite Bio presents additional analysis from Phase 2 study of tinlarebant
2M ago
BLTE
Belite Bio to participate on KOL Webinar to discuss STGD1, GA
PremiumThe Fly
Belite Bio to participate on KOL Webinar to discuss STGD1, GA
2M ago
BLTE
Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant
PremiumPress Releases
Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant
2M ago
BLTE
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
PremiumPress ReleasesBelite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
2M ago
BLTE
Belite Bio, Inc Announces New Securities Agreement
PremiumCompany Announcements
Belite Bio, Inc Announces New Securities Agreement
2M ago
6K
BLTE
Belite Bio Advances Retinal Disease Treatment
PremiumCompany Announcements
Belite Bio Advances Retinal Disease Treatment
4M ago
6K
BLTE
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
PremiumPress Releases
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
4M ago
BLTE
Belite Bio announces PMDA submission of Tinlarebant for trial in Japan
PremiumThe Fly
Belite Bio announces PMDA submission of Tinlarebant for trial in Japan
4M ago
BLTE
Belite Bio reports Q4 EPS (27c), consensus (30c)
PremiumThe Fly
Belite Bio reports Q4 EPS (27c), consensus (30c)
4M ago
BLTE
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
PremiumPress Releases
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
4M ago
BLTE
Belite Bio reports Q4 EPS (27c), consensus (30c)
PremiumThe FlyBelite Bio reports Q4 EPS (27c), consensus (30c)
4M ago
BLTE
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
4M ago
BLTE
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results
PremiumPress Releases
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results
4M ago
BLTE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >